Wenbin Ma

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

End Stage Renal Disease

Cerebrospinal Fluid

Top Venues

Cancer medicine

CNS neuroscience & therapeutics

Biomechanics and modeling in mechanobiology

This page only lists publications with an associated author ORCID identifier.

Publications

Liguo Ye, Lingui Gu, Yaning Wang, Hao Xing, Pengtao Li, Xiaopeng Guo, Yu Wang, Wenbin Ma
Identification of TMZ resistance-associated histone post-translational modifications in glioblastoma using multi-omics data. CNS neuroscience & therapeutics 30 (3) (2024)
Yuekun Wang, Hao Xing, Xiaopeng Guo, Wenlin Chen, Yaning Wang, Tingyu Liang, Hai Wang, Yilin Li, Shanmu Jin, Yixin Shi, Delin Liu, Tianrui Yang, Yu Xia, Junlin Li, Jiaming Wu, Qianshu Liu, Tian Qu, Siying Guo, Huanzhang Li, Kun Zhang, Yu Wang, Wenbin Ma
Clinical features, MRI, molecular alternations, and prognosis of astrocytoma based on WHO 2021 classification of central nervous system tumors: A single-center retrospective study. Cancer medicine 13 (13) (2024)
Yuekun Wang, Hao Xing, Xiaopeng Guo, Wenlin Chen, Yaning Wang, Tingyu Liang, Hai Wang, Yilin Li, Shanmu Jin, Yixin Shi, Delin Liu, Tianrui Yang, Yu Xia, Junlin Li, Jiaming Wu, Qianshu Liu, Tian Qu, Siying Guo, Huanzhang Li, Kun Zhang, Yu Wang, Wenbin Ma
Clinical features, MRI, molecular alternations, and prognosis of astrocytoma based on WHO 2021 classification of central nervous system tumors: A single-center retrospective study. Cancer medicine 13 (13) (2024)
Liguo Ye, Lingui Gu, Yaning Wang, Hao Xing, Pengtao Li, Xiaopeng Guo, Yu Wang, Wenbin Ma
Identification of TMZ resistance-associated histone post-translational modifications in glioblastoma using multi-omics data. CNS neuroscience & therapeutics 30 (3) (2024)
Yaning Wang, Zihao Wang, Xiaopeng Guo, Yaning Cao, Hao Xing, Yuekun Wang, Bing Xing, Yu Wang, Yong Yao, Wenbin Ma
Artificial neural network identified a 20-gene panel in predicting immunotherapy response and survival benefits after anti-PD1/PD-L1 treatment in glioblastoma patients. Cancer medicine 13 (9) (2024)
Liguo Ye, Lingui Gu, Yaning Wang, Hao Xing, Pengtao Li, Xiaopeng Guo, Yu Wang, Wenbin Ma
Identification of TMZ resistance-associated histone post-translational modifications in glioblastoma using multi-omics data. CNS neuroscience & therapeutics 30 (3) (2024)
Yaning Wang, Zihao Wang, Xiaopeng Guo, Yaning Cao, Hao Xing, Yuekun Wang, Bing Xing, Yu Wang, Yong Yao, Wenbin Ma
Artificial neural network identified a 20-gene panel in predicting immunotherapy response and survival benefits after anti-PD1/PD-L1 treatment in glioblastoma patients. Cancer medicine 13 (9) (2024)
Yaning Wang, Zihao Wang, Xiaopeng Guo, Yaning Cao, Hao Xing, Yuekun Wang, Bing Xing, Yu Wang, Yong Yao, Wenbin Ma
Artificial neural network identified a 20-gene panel in predicting immunotherapy response and survival benefits after anti-PD1/PD-L1 treatment in glioblastoma patients. Cancer medicine 13 (9) (2024)
Binghao Zhao, Jiaming Wu, Huanzhang Li, Yuekun Wang, Yaning Wang, Hao Xing, Yu Wang, Wenbin Ma
Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma. Cell communication and signaling : CCS 21 (1) (2023)
Binghao Zhao, Jiaming Wu, Huanzhang Li, Wenbin Ma
Final Report of EORTC 26951 and RTOG 9402 for Anaplastic Oligodendroglial Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Xin Yang, Penghao Liu, Hao Xing, Xiaoyan Wen, Yu Wang, Chunhua Hu, Luming Li, Wenbin Ma
Skull modulated strategies to intensify tumor treating fields on brain tumor: a finite element study. Biomechanics and modeling in mechanobiology 21 (4) (2022)
Binghao Zhao, Huanzhang Li, Yu Xia, Yaning Wang, Yuekun Wang, Yixin Shi, Hao Xing, Tian Qu, Yu Wang, Wenbin Ma
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy. Journal of hematology & oncology 15 (1) (2022)
Penghao Liu, Yaning Wang, Yuekun Wang, Ziren Kong, Wanqi Chen, Jiatong Li, Wenlin Chen, Yuanren Tong, Wenbin Ma, Yu Wang
Effects of oncolytic viruses and viral vectors on immunity in glioblastoma. Gene therapy (2020)